BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1496260)

  • 1. The variations of the serum IgD and of the circulant immune complexes in diabetic patients.
    Cheţa D; Cojocaru M; Mogoş T; Iosif C; Cheţa N; Trifan E; Alexandrescu R; Halmagy I; Enache M
    Rom J Intern Med; 1992; 30(1):57-62. PubMed ID: 1496260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in diabetic patients with periodontitis.
    Anil S; Remani P; Ankathil R; Vijayakumar T
    Ann Dent; 1990; 49(2):3-5, 45. PubMed ID: 2278478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune complexes in diabetes mellitus].
    Kocić R; Radenković S; Milenović M; Mijailović M; Koraćević G; Zivić S; Pesić M; Kosić G
    Srp Arh Celok Lek; 1994; 122 Suppl 1():60-3. PubMed ID: 18173190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
    Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
    Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
    Triolo G; Giardina E; Bompiani GD
    J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
    Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
    Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
    Triolo G; Giardina E; Seddio G; Terrizzi C
    Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus.
    Aughsteen AA; Abu-Umair MS; Mahmoud SA
    Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in the blood of diabetics with diabetic retinopathies].
    Saldan IR; Vanichkin AA; Mikhel'tseva IN
    Oftalmol Zh; 1986; (1):45-7. PubMed ID: 3703449
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
    Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
    Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
    González M; Rojas N; Durán D; Schade A; Campos R; Milos C
    Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the types of diabetes mellitus in first degree relatives of diabetic patients.
    Cheţa D; Dumitrescu C; Georgescu M; Cocioabă G; Lichiardopol R; Stamoran M; Ionescu-Tîrgovişte C; Păunescu-Georgescu M; Mincu I
    Diabete Metab; 1990; 16(1):11-5. PubMed ID: 2332093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
    Casiglia D; Giardina E; Scarantino G; Triolo G
    Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.